Teva Launches Generic HIV Drug

Article

Atazanavir (Reytaz) is indicated to treat patients with an HIV-1 infection.

Teva Pharmaceutical Industries recently announced the launch of a generic version of atazanavir (Reyataz) capsules, according to a company press release.

Atazanir sulfate is a protease inhibitor approved as part of a combination of antiretroviral drugs for HIV-positive patients 6 years and older.

In clinical trials, approximately 20% of patients treated with atazanavir sulfate developed a rash. Teva reported that some patients also developed Stevens-Johnson syndrome, erythema multiforme, and toxic skin eruptions, according to the press release.

Additionally, the most common adverse reactions include nausea, jaundice/scleral icterus, rash, headache, abdominal pain, vomiting, insomnia, peripheral neurologic symptoms, dizziness, myalgia, diarrhea, depression, and fever, according to the release.

Teva said that Rayataz had sales of $402 million in the United States, as indicated by October 2017 IMS data.

The launch of the generic drug may increase patient access to low-cost antiviral treatment and help prevent the spread of HIV, according to the release.

“The exclusive launch of our generic version of Reyataz marks our fifth generic product offering for the treatment of HIV-1 infection,” said Brendan O’Grady, executive vice president, North America Commercial at Teva. “Antiviral medications continue to be a focus for Teva Generics, and this is an important addition to our portfolio.”

Related Videos
male pharmacist using digital tablet during inventory in pharmacy | Image Credit: sofiko14 - stock.adobe.com
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Biosimilar pharmaceutical drug bottle on blue background. | Image Credit: Carl - stock.adobe.com
Pharmaceutical manufacture background with glass bottles with clear liquid on automatic conveyor line. | Image Credit: wacomka - stock.adobe.com
Bottle and scattered pills on color background, top view | Image Credit: New Africa - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.